FDA NDC Directory · JSON-LD · Markdown

XELJANZ XR

NDC 63539-502 · HUMAN PRESCRIPTION DRUG · TABLET, EXTENDED RELEASE

Generic nametofacitinib
Labeler / ManufacturerU.S. Pharmaceuticals
Marketing categoryNew Drug Application (innovator) · App NDA208246
Dosage form / routeTABLET, EXTENDED RELEASE · ORAL
Active ingredientsTOFACITINIB CITRATE (22 mg/1)
Marketing started20200121
Package count1

External sources

Source: openFDA. Public-domain (CC0).